2010 - Intensive blood pressure control did not prevent major CV events more than standard control in type 2 diabetes

Elley, C. Raina; Selak, Vanessa
July 2010
ACP Journal Club;7/20/2010, Vol. 153 Issue 1, p3
Academic Journal
The article presents the author's views on a research study which compared the effectiveness of intensive antihypertensive therapy and standard therapy in reducing cardiovascular (CV) risk in patients of type two diabetes who are at high risk of CV. The study concluded that there was no advantage one therapy to the other. The author observes that the outcome of the research was similar to another research which also found relative risk reduction (RRR) of 15% compared 20% of the current study.


Related Articles

  • Management of Type 2 Diabetes Mellitus and Cardiovascular Risk: Lessons from Intervention Trials. Yki-J√§rvinen, H. // Drugs;Nov2000, Vol. 60 Issue 5, p975 

    Although the diagnosis of type 2 (noninsulin-dependent) diabetes mellitus is made when blood glucose levels exceed values which increase the risk of microvascular complications, macrovascular disease is the major complication of type 2 diabetes mellitus. Both epidemiological and prospective data...

  • Managing diabetic nephropathy. Popat, Reena J. // Independent Nurse;7/16/2012, p34 

    The article describes "diabetic nephropathy," a complication of diabetes mellitus and a common cause of end-stage kidney disease across the world. It emphasizes on screening for microalbuminuria persistent low levels of albumin in the urine, and tackling its risk factors, including,...

  • How risky is diabetes 2? Napoli, Maryann // Center for Medical Consumers;Apr2011, p1 

    The article offers information about the British Regional Heart Study, a study led by Dr. S. Goya Wannamethee of the University College in London, Great Britain which assessed men who were screened for diabetes 2 from 1978 to 1980. Results showed that 9% of the men without diabetes or heart...

  • A cross-sectional study of the effects of type 2 diabetes and other cardiovascular risk factors on structure and function of nonstenotic arteries of the lower limb. O'Neal, David N.; Dragicevic, George; Rowley, Kevin G.; Ansari, Mohamed Z.; Balazs, Nicholas; Jenkins, Alicia; Best, James D. // Diabetes Care;Jan2003, Vol. 26 Issue 1, p199 

    Objective: To compare intimal-medial thickness (IMT) and pulse wave conduction velocity (PWCV) in unstenosed arteries of the lower limb in subjects with and without type 2 diabetes and to determine the contribution of a range of cardiovascular risk factors. Research Design and...

  • Prescription medication burden in patients with newly diagnosed diabetes: A Surveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study. Schmittdiel, Julie A.; Raebel, Marsha A.; Dyer, Wendy; Xu, Stanley; Goodrich, Glenn K.; Schroeder, Emily B.; Segal, Jodi B.; O'Connor, Patrick J.; Nichols, Gregory A.; Lawrence, Jean M.; Kirchner, H. Lester; Karter, Andy J.; Lafata, Jennifer Elston; Butler, Melissa G.; Steiner, John F. // Journal of the American Pharmacists Association: JAPhA;Jul/Aug2014, Vol. 54 Issue 4, p374 

    Objective: To understand the burden of medication use for patients with newly diagnosed diabetes both before and after diabetes diagnosis and to identify subpopulations of patients with newly diagnosed diabetes who face a relatively high drug burden. Design: Retrospective cohort study. Setting:...

  • Clinical Efficacy of Orlistat Therapy in Overweight and Obese Patients With Insulin-Treated Type 2 Diabetes. Kelley, David E.; Bray, George A.; Pi-Sunyer, F. Xavier; Klein, Samuel; Hill, James; Miles, John; Hollander, Priscilla // Diabetes Care;Jun2002, Vol. 25 Issue 6, p1033 

    Focuses on a study that assessed the effect of orlistat on weight loss, glycemic control and cardiovascular risk factors in overweight or obese insulin-treated type 2 diabetic patients. Research design and methods; Results; Conclusions.

  • AHA Examines Cardiovascular Problems in Diabetes. Morey, Sharon Scott // American Family Physician;01/15/2000, Vol. 61 Issue 2, p561 

    Summarizes the recommendations issued by the American Heart Association for reducing the risk of cardiovascular disease and its complications in patients with diabetes mellitus. Risk factors for cardiovascular disease; Risk assessment and clinical evaluation; Journal where the recommendations...

  • Heart-Smart Cuisine. Gidus, Tara // Orlando Home & Leisure;Jan2012, Vol. 13 Issue 1, Special section p6 

    The article offers tips on cutting risks of having cardiovascular diseases. These diseases are major causes of mortalities in the U.S., where diet is the main cause of disease risk factors like high-blood pressure, obesity, and diabetes. Various dietary actions can be done to mitigate heart...

  • Prevalences of diabetes and cardiovascular disease risk factors in Hindu Indian subcommunities in Tanzania. Ramaiya, K.L.; Swai, A.B.M.; McLarty, D.G.; Bhopal, R.S.; Alberti, K.G.M.M. // BMJ: British Medical Journal (International Edition);8/3/91, Vol. 303 Issue 6797, p271 

    Examines the prevalence of diabetes and cardiovascular disease risk factors in Hindu Indian subcommunities in Dar-es-Salaam, Tanzania. Consideration on the socioeconomic characteristics and lifestyle of the population; Exploration on the genetic basis of diabetes; Determination of insulin...

  • MedSurg Minute.  // MEDSURG Nursing;Aug99, Vol. 8 Issue 4, p227 

    Offers information on cardiovascular disease as a complication of diabetes. Significance of early diagnosis and intervention; Statistics on the incidence of atherosclerotic damage to the coronary arteries in people with diabetes.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics